Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Sing George L sold 2,000 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 16 to Nov 17, 2026 · Filed Nov 18, 2026
From Nov 16 to Nov 17, 2026, Sing George L (Director) sold 2,000 Regeneron Pharmaceuticals, Inc. shares at an average US$958.97 for US$1.92M, leaving 23,147 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 2,000 shares
- Price
- US$958.97 average (US$956.96 to US$960.26)
- Value
- US$1.92M
- Holding after
- 23,147 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Sale | 1,000 | US$960.26 | 24,147 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 176 | US$956.96 | 23,971 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 359 | US$957.49 | 23,612 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 465 | US$958.11 | 23,147 | Direct |
Source
Download original · View original at SEC
Related
- Regeneron Pharmaceuticals, Inc.
- Sing George L
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · Sing George L · Nov 4, 2026
- Form 4 · Murphy Andrew J · Nov 18, 2026
- Form 4 · McCourt Marion · Nov 18, 2026
- Form 4 · Pitofsky Jason · Nov 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026